ReviewCanadian family physician Medecin de famille canadien2008
Update on pharmacologic and nonpharmacologic therapies for smoking cessation.
Review in Canadian family physician Medecin de famille canadien, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Does the use of ingredients added to tobacco increase cigarette addictiveness?: a detailed analysis.Inhalation toxicology · 2012Pooled it
- How can dementia and disability be prevented in older adults: where are we today and where are we going?Journal of internal medicine · 2021Review
- Global research mapping of substance use disorder and treatment 1971-2017: implications for priority setting.Substance abuse treatment, prevention, and policy · 2019Article
- [Psychotherapy and pharmacotherapy for harmful tobacco use and tobacco dependency].Der Nervenarzt · 2016Article
- Patients' awareness of the surgical risks of smoking: Implications for supporting smoking cessation.Canadian family physician Medecin de famille canadien · 2015Article
- Smoking cessation and neuropsychiatric adverse events: are family physicians caught between a rock and a hard place?Canadian family physician Medecin de famille canadien · 2011Article
- Evaluation of a student-run smoking cessation clinic for a medically underserved population.BMC research notes · 2011Article
- Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.International journal of environmental research and public health · 2009Review
- A thematic analysis of theoretical models for translational science in nursing: mapping the field.Nursing outlookReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo review the evidence on the efficacy and safety of pharmacologic and nonpharmacologic therapies for smoking cessation. QUALITY OF EVIDENCE: MEDLINE, EMBASE, and the Cochrane Database of Systematic Reviews were searched for randomized controlled trials, meta-analyses, and systematic reviews (level I evidence) pertinent to pharmacologic and nonpharmacologic smoking cessation therapies. MAIN MESSAGE: Pharmacologic smoking cessation aids are recommended for all smokers trying to quit, unless contraindicated. A new pharmacologic smoking cessation aid, varenicline, is now available in Canada. Level I evidence at 1-year follow-up indicates that it is effective for smoking cessation. Adverse effects include nausea, insomnia, and abnormal dreaming. Nausea is mild or moderate and decreases over time. Varenicline is more effective than placebo or bupropion. Counseling also increases the likelihood of achieving cessation.
conclusionPreliminary data indicate that varenicline is more effective than other available pharmacologic smoking cessation aids. Pharmacologic therapy should be combined with nonpharmacologic therapy.
Indexed as
Identifiers
18625823PMC2464816What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.